Trials / Not Yet Recruiting
Not Yet RecruitingNCT06668896
Comparing the Pharmacokinetics of a Progesterone Ring Versus a Progesterone Vaginal Insert
An Open-Label, Four-Treatment, Parallel Study of the Comparative Pharmacokinetics of a Progesterone Intravaginal Ring (IVR) 8 mg and 12 mg/Day Versus Progesterone Vaginal Insert 100mg
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Daré Bioscience, Inc. · Industry
- Sex
- Female
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study is looking for healthy female adults to use an vaginal ring with differing amounts of the hormone progesterone and go through a series of blood draws to measure how much progesterone is in the body following the use of these vaginal rings over an extended period of time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Progesterone | Each arm will administer different amounts of progesterone vaginally (8mg to 100mg) over a 14-15 day time period. |
Timeline
- Start date
- 2025-11-01
- Primary completion
- 2026-01-01
- Completion
- 2026-06-01
- First posted
- 2024-11-01
- Last updated
- 2025-09-08
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06668896. Inclusion in this directory is not an endorsement.